Passing through this signaling pathway, the immunohistochemical findings revealed that ETA translocated NF-κB, a downstream molecule of TLR4, to the nucleoli and disabled the progression of NASH to fibrosis via TGF-β1 suppression. Here, TLR4 is linked to metabolic dysfunction-associated steatohepatitis.